Hits Glaukos New All-time High on Q2 Results, Raised 2026 Revenue Guidance
Glaukos (GKOS) hit a new all-time high on Thursday of $183.40, buoyed by Q2 financial results that beat on both lines and increasing its full-year revenue guidance. The ophthalmic company now sees 2026 revenue of $680M-$700M, up from $620M-$635M prior Consensus is $